Vivos Therapeutics Inc (VVOS)
2.24
-0.05
(-2.18%)
USD |
NASDAQ |
May 20, 16:00
2.12
-0.12
(-5.36%)
Pre-Market: 08:58
Vivos Therapeutics Profit Margin (Quarterly): -110.1% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -110.1% |
December 31, 2023 | -131.1% |
September 30, 2023 | -63.40% |
June 30, 2023 | -162.8% |
March 31, 2023 | -44.15% |
December 31, 2022 | -154.2% |
September 30, 2022 | -128.0% |
June 30, 2022 | -167.1% |
March 31, 2022 | -146.3% |
December 31, 2021 | -168.3% |
Date | Value |
---|---|
September 30, 2021 | -120.0% |
June 30, 2021 | -89.90% |
March 31, 2021 | -98.58% |
December 31, 2020 | -189.0% |
September 30, 2020 | -55.08% |
June 30, 2020 | -43.22% |
March 31, 2020 | -80.73% |
December 31, 2019 | -85.97% |
September 30, 2019 | -93.24% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-189.0%
Minimum
Dec 2020
-43.22%
Maximum
Jun 2020
-112.2%
Average
-110.1%
Median
Mar 2024
Profit Margin (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Electromed Inc | 10.76% |
Xtant Medical Holdings Inc | -15.79% |
Asensus Surgical Inc | -2.00K% |
Senseonics Holdings Inc | -374.0% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -771.5% |
Return on Assets | -122.8% |
Return on Invested Capital | -771.5% |
Gross Profit Margin (Quarterly) | 56.65% |
Operating Margin (Quarterly) | -110.7% |
Return on Net Operating Assets | -187.8% |